Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.4500 (-1.18%) ($17.8100 - $18.6700) on Fri. Dec. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 55 | Latest Price | $18.4500(-1.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(55%) XBI(54%) IWM(51%) ARKG(49%) | Factors Impacting HALO price | HALO will decline at least -1.79% in a week (0% probabilities). VIXM(-12%) UUP(-12%) TLT(-6%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $18.65(-1.07%) | 10 Day Moving Average | $18.65(-1.07%) | 20 Day Moving Average | $18.36(0.49%) | To recent high | -3.9% | To recent low | 42.9% | Market Cap | $2.522b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |